The global Prenatal and New-born Genetic Testing Market was valued at USD 4.5 Billion in 2022 and it is anticipated to grow up to USD 20.9 Billion by 2032, at a CAGR of 16.6% during the forecast period.
Get Access to A Free Sample Copy of Our Latest Report – https://www.globalinsightservices.com/request-sample/GIS10516
Prenatal testing provides you with information about your baby’s health. It detects any problems that could affect the health of fetuses like genetic defects and congenital conditions. Doctors recommend some prenatal tests while only a few women need special screening tests. Newborn testing is done to detect abnormalities that can cause certain health conditions such as inborn genetic defects. The genetic diseases that can be detected in newborns during screening are Down syndrome, phenylketonuria, homocystinuria, and others. Therefore it is important to diagnose genetic diseases in the early stages of the pregnancy and within 24 hours of newborn birth.
Market Trends and Drivers
Growing consanguineous relations in African and Asian countries is expected to stimulate the market expansion
Growing rate of traditional consanguineous marriages that fuels the risk of autosomal recessive disorders in the newborn is amongst the key factors boosting the prenatal and new-born genetic testing market progression. Marrying in closely related family members is tradition in several countries in Middle East, West Asia, East Asia and North Africa region with almost half of the marriages being consanguineous. The emigrant from these regions continue the tradition and are contributing to the surging rates of genetic disorders. Consanguineous marriage results in transfer of two recessive defective mechanisms from the parents and the offspring may inherit these genes causing the congenital anomalies. Around 1 billion people reside in the countries that commonly practice marriage among relatives. Amongst them, 1 out of 3 individuals are married to a second cousin or closely related family member. The risk of having genetic defects or chromosomal abnormalities among offspring of such marriages is almost two-fold.
View Detailed Report Description – https://www.globalinsightservices.com/reports/prenatal-and-newborn-genetic-testing-market/
Market Restraints and Challenges
The chances of miscarriage due to some of the prenatal testing is the main hurdle limiting the growth of the prenatal and newborn genetic testing market. For instance, amniocentesis is the most commonly performed non-invasive prenatal test during the second trimester of pregnancy have a chance of miscarriage. In addition, the high cost of screening methods and diagnostic tests is anticipated to hamper the growth of the market. For instance, chronic villus sampling costs around $3,050.
Major Players in the Global Prenatal and New-born Genetic Testing Market
The key players in the Prenatal and New-born Genetic Testing Market are Ariosa Diagnostics (Roche), Berry Genomics, BGI, Biorad, Illumina, Laboratory Corporation of America, Natera, Qiagen, Sequenom, Trivitron Healthcare and Verinata Health among others.
Get a customized scope to match your need, ask an expert – https://www.globalinsightservices.com/request-customization/GIS10516
COVID-19 Impact:
The outbreak of COVID-19 has disrupted workflows in the healthcare sector around the world. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of health care. The global prenatal and newborn genetic testing market experienced a decline in 2020 due to the global economic recession led by COVID-19. In addition, the COVID-19 outbreak disrupted the supply chain across various end-user industries like food & beverage, healthcare, and industrial. However, the market is anticipated to witness recovery in 2021, and show stable growth for prenatal and newborn genetic testing market in the coming future. This is attributed to the increase in the adoption novel screening methods in developing countries such as China and India.
Global Prenatal and New-born Genetic Testing Market Segmentation
By Technology
- Screening
- Diagnostics
By Disease
- Downs Syndrome
- Phenylketonuria
- Cystic Fibrosis
- Sickle Cell Anemia
- Others
By End-use
- Hospitals
- Maternity & Specialty Clinics
- Diagnostic Centers
Buy Now – https://www.globalinsightservices.com/checkout/single_user/GIS10516
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
New Report Published by Global Insight Services – https://www.globalinsightservices.com/reports/hydrogen-projects-database/?utm_source=utm_source%3Dlinkewire_pranali_pawar&utm_medium=member_desktop
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/